(Q85575147)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23197042%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

The predicated demise of racemic new molecular entities is an exaggeration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23197042%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Israel Agranat

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23197042%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Silvya R Wainschtein

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23197042%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Enav Z Zusman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23197042%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23197042%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Drug Discovery

19 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23197042%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23197042%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23197042%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

972-973

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23197042%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

cites work

2011 FDA drug approvals

1 reference

https://api.crossref.org/works/10.1038%2FNRD3657-C1

Putting chirality to work: the strategy of chiral switches

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD3657-C1

Trends in the development of chiral drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD3657-C1

Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD3657-C1

The strategy of enantiomer patents of drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD3657-C1

FDA's policy statement for the development of new stereoisomeric drugs

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23197042